CoChat

Protection against stroke with glucagon‐like peptide 1 receptor agonists: a systematic review and meta‐analysis

Barkas, F., Elisaf, M., Milionis, H. · 2019 · European Journal of Neurology
Cited by 43

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

In experimental stroke models pretreatment with the newly introduced antidiabetic agents, glucagon‐like peptide 1 receptor (GLP‐1R) agonists, has been shown to exert neuroprotective effects. Published evidence with regard to the effect of treatment with GLP‐1R agonists on the risk of stroke was evaluated. Data from prospective randomized placebo‐controlled trials up to October 2018 involving GLP‐1R agonists which reported cardiovascular outcomes as primary end‐points of efficacy and/or safety were meta‐analysed. Five eligible multicentre randomized placebo‐controlled trials (ELIXA, LEADER, SUSTAIN, EXSCEL and HARMONY) were included. The pooled analysis (n = 42 358) showed a significant reduction by 13% in the risk of total stroke from treatment with GLP‐1R agonists versus placebo (risk ratio 0.87, 95% confidence interval 0.78–0.98, P = 0.021) with no significant heterogeneity between trials (Q = 4.094, P = 0.393, I2 = 2.307%). When only fatal stroke was included (this applied for the ELIXA, LEADER, EXSCEL and HARMONY trials), active treatment was associated with a non‐significant reduction by 16% compared with placebo (risk ratio 0.84, 95% confidence interval 0.60–1.17, P = 0.29). The findings of this meta‐analysis support the evidence from earlier experimental studies calling attention to potential ‘stroke protective’ effects from treatment with GLP‐1R.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/ene.13905

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 15

  1. 10.1002/dmrr.568 · DOI · Paper page
  2. 10.1016/S1474-4422(12)70005-4 · DOI · Paper page
  3. 10.1038/jcbfm.2015.17 · DOI · Paper page
  4. 10.1007/s11154-014-9285-9 · DOI
  5. 10.1016/S2213-8587(13)70125-6 · DOI
  6. 10.1161/01.STR.0000257974.06317.49 · DOI · Paper page
  7. 10.1016/j.diabet.2016.10.006 · DOI
  8. 10.1056/NEJMoa1612917 · DOI · Paper page
  9. 10.2337/dc15-2145 · DOI · Paper page
  10. 10.2337/dc10-1393 · DOI · Paper page
  11. 10.1111/dom.12175 · DOI · Paper page
  12. 10.1001/jama.2016.9400 · DOI · Paper page
  13. 10.1016/j.ijcard.2017.03.163 · DOI
  14. 10.2174/1573399813666170414101450 · DOI
  15. 10.1177/1747493018784436 · DOI

Cited by

See all 43

Metadata

Authors
Barkas, F., Elisaf, M., & Milionis, H.
Venue
European Journal of Neurology
Publisher
Wiley
Published
2019-01-30
Volume
26
Issue
4
Pages
559-565
ISSN
  • 1351-5101 (ISSN-L)
  • 1468-1331
OpenAlex
W2908687677
Cited by
43
References
10
FWCI
1.21
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Protection against stroke with glucagon‐like peptide 1 receptor agonists: a systematic review and meta‐analysis. https://app.cochat.ai/papers/10.1111/ene.13905
The paper
Barkas, F., Elisaf, M., & Milionis, H. (2019). Protection against stroke with glucagon‐like peptide 1 receptor agonists: a systematic review and meta‐analysis. European Journal of Neurology. https://doi.org/10.1111/ene.13905

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.